Shubin Wang
Shijiazhuang, 050011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
LINC00514 regulates oral squamous cell carcinoma progression and prognosis by targeting miR-195-5p.
Journal: BMC oral health
Published: September 08, 2025
Secretogranin II serves as a potential prognostic biomarker and correlates with the immune microenvironment in pancreatic neuroendocrine tumors.
Journal: Translational cancer research
Published: July 18, 2025
STRIP2 promotes hepatocellular carcinoma progression and immune evasion: a potential prognostic biomarker and therapeutic target.
Journal: Journal of gastrointestinal oncology
Published: March 27, 2025
An integrated analysis identified mitochondrial ribosomal protein MRPL3 as a potential prognostic biomarker and therapeutic target in pancreatic cancer.
Journal: Journal of Cancer
Published: March 20, 2025
Role of CD28+ PD-1+ Tc cells in immune response and prognosis prediction in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: February 13, 2025
Impact of preoperative blood glucose levels on prognosis and postoperative complications in patients with pancreatic cancer.
Journal: Oncology letters
Published: September 26, 2024
SCG2 and CPE may be novel markers for the identification of pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms.
Journal: Translational cancer research
Published: February 07, 2024
Molecular docking and in vitro experiments verified that kaempferol induced apoptosis and inhibited human HepG2 cell proliferation by targeting BAX, CDK1, and JUN.
Journal: Molecular and cellular biochemistry
Published: March 15, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026